- Home
- SCOR vs KZR Comparison
SCOR vs KZR Comparison
Compare SCOR & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- KZR
- Stock Information
- Founded
- SCOR 1999
- KZR 2015
- Country
- SCOR United States
- KZR United States
- Employees
- SCOR N/A
- KZR N/A
- Industry
- SCOR Business Services
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- KZR Health Care
- Exchange
- SCOR Nasdaq
- KZR Nasdaq
- Market Cap
- SCOR 37.1M
- KZR 29.7M
- IPO Year
- SCOR 2007
- KZR 2018
- Fundamental
- Price
- SCOR $7.17
- KZR $6.20
- Analyst Decision
- SCOR
- KZR Hold
- Analyst Count
- SCOR 0
- KZR 4
- Target Price
- SCOR N/A
- KZR $6.00
- AVG Volume (30 Days)
- SCOR 160.8K
- KZR 452.6K
- Earning Date
- SCOR 11-04-2025
- KZR 11-11-2025
- Dividend Yield
- SCOR N/A
- KZR N/A
- EPS Growth
- SCOR N/A
- KZR N/A
- EPS
- SCOR N/A
- KZR N/A
- Revenue
- SCOR $358,513,000.00
- KZR N/A
- Revenue This Year
- SCOR $3.45
- KZR N/A
- Revenue Next Year
- SCOR $2.59
- KZR N/A
- P/E Ratio
- SCOR N/A
- KZR N/A
- Revenue Growth
- SCOR N/A
- KZR N/A
- 52 Week Low
- SCOR $4.39
- KZR $3.53
- 52 Week High
- SCOR $10.18
- KZR $8.45
- Technical
- Relative Strength Index (RSI)
- SCOR 45.53
- KZR 79.31
- Support Level
- SCOR $7.36
- KZR $5.95
- Resistance Level
- SCOR $7.86
- KZR $4.45
- Average True Range (ATR)
- SCOR 0.46
- KZR 0.31
- MACD
- SCOR -0.15
- KZR 0.24
- Stochastic Oscillator
- SCOR 2.13
- KZR 93.02
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.